SCHOTT Pharma AG & Co. KGaA (ETR:1SXP)
Germany · Delayed Price · Currency is EUR 20.20
-0.15 (-0.74%)
At close: Jul 24, 2026
ETR:1SXP Financials Overview
Financials in millions EUR. Fiscal year is October - September.
Millions EUR. Fiscal year is Oct - Sep.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
Revenue Revenue Growth | 992.11 | 986.21 | 957.09 | 180.01 | 821.14 |
Revenue Growth | 1.89% | 3.04% | 431.68% | -78.08% | - |
Gross Profit Gross Profit Growth | 327.03 | 332.46 | 322.61 | 129.75 | 296.43 |
Operating Income Operating Income Growth | 194.99 | 200.82 | 192.58 | 21.84 | 164.38 |
Net Income Net Income Growth | 143.31 | 146.45 | 149.69 | 43.55 | 125.38 |
Earnings Per Share EPS Growth | 0.95 | 0.97 | 0.99 | 1.01 | 0.83 |
EPS Growth | -3.06% | -2.02% | -1.98% | 21.69% | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Drug Containment Solutions (DCS) Drug Containment Solutions (DCS) Growth | 563.34 | 548.01 | 518.72 | 558 | 598.92 | 492.13 |
Drug Delivery Solutions (DDS) Drug Delivery Solutions (DDS) Growth | 428.37 | 438.76 | 438.74 | 343.64 | 222.86 | 157.68 |
Consolidation/Reconciliation Consolidation/Reconciliation Growth | -0.48 | -0.56 | -0.37 | -3.03 | -0.64 | -1.14 |
Total Total Growth | 991.22 | 986.21 | 957.09 | 898.6 | 821.14 | 648.67 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
Cash & Investments Cash & Investments Growth | 27.81 | 22.47 | 23.18 | 0 | 28.8 |
Total Debt Total Debt Growth | 301.84 | 299.18 | 281.62 | 0 | 192.07 |
Net Cash (Debt) Net Cash Growth | -274.03 | -276.71 | -258.44 | -0 | -163.27 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -1.82 | -1.84 | -1.72 | - | -1.08 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 202.46 | 179.92 | 224.77 | 181.65 | 182.12 |
Capital Expenditures CapEx Growth | -143.42 | -144.32 | -145.08 | -175.47 | -152.01 |
Free Cash Flow Free Cash Flow Growth | 59.04 | 35.6 | 79.69 | 6.19 | 30.11 |
Free Cash Flow Growth | -11.30% | -55.33% | 1188.50% | -79.46% | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
Gross Margin | 32.96% | 33.71% | 33.71% | 72.08% | 36.10% |
Operating Margin | 19.65% | 20.36% | 20.12% | 12.13% | 20.02% |
Pretax Margin | 18.57% | 19.04% | 19.22% | 32.10% | 19.28% |
Profit Margin | 14.50% | 14.90% | 15.71% | 24.19% | 15.33% |
FCF Margin | 5.95% | 3.61% | 8.33% | 3.44% | 3.67% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 27, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.180 | 0.180 | 0.160 | 0.150 | 0.125 |
Dividend Per Share Growth | 12.50% | 12.50% | 6.67% | 20.00% | - |
Dividend Yield | 0.88% | 0.76% | 0.49% | 0.40% | - |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 27, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
PE Ratio | 21.25 | 21.65 | 30.97 | 31.33 | - |
Forward PE | 19.95 | 19.36 | 30.23 | - | - |
P/FCF Ratio | 51.53 | 88.85 | 57.94 | 770.48 | - |
PS Ratio | 3.07 | 3.21 | 4.82 | 26.47 | - |